Results 71 to 80 of about 822,808 (285)

Does SARS-CoV-2 cause viral myocarditis in COVID-19 patients?

open access: yesEuropean Heart Journal, 2020
Since the first cases reported in Wuhan, China, coronavirus disease 2019 (COVID-19) has spread swiftly around the world, and is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Ruihai Zhou
semanticscholar   +1 more source

Investigation into the Pancreatic Pathogenesis of SFTSV across Multiple Levels

open access: yesAdvanced Science, EarlyView.
A retrospective analysis revealed that 17.6% of severe fever with thrombocytopenia syndrome (SFTS) patients met the diagnostic criteria for clinically confirmed pancreatitis. Using human pancreatic organoids and murine models demonstrated that SFTSV exhibits a specific pancreatic tropism, leading to cell death and initiating a strong inflammatory ...
Xiaohan Liu   +10 more
wiley   +1 more source

Mycoplasma pneumonia : an unusual cause of acute myocarditis in childhood [PDF]

open access: yes, 2006
Mycoplasma pneumoniae is primarily a respiratory pathogen but may affect exhibit a diverse range of presentations from asymptomatic infection to life threatening conditions. Myocarditis of varying severity is an unusual complication.
Bailey, Mark   +4 more
core  

The Role of Non-coding RNAs in Viral Myocarditis

open access: yesFrontiers in Cellular and Infection Microbiology, 2020
Viral myocarditis (VMC) is a disease characterized as myocardial parenchyma or interstitium inflammation caused by virus infection, especially Coxsackievirus B3 (CVB3) infection, which has no accurate non-invasive examination for diagnosis and specific ...
Cong Zhang   +6 more
semanticscholar   +1 more source

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli   +17 more
wiley   +1 more source

Cardiogenic shock associated with acute norovirus gastroenteritis: what is needed to prove causality?

open access: yesEuropean Journal of Case Reports in Internal Medicine, 2023
Acute myocarditis is a well-recognized condition attributable to a variety of viral illnesses. Common viral aetiologies include enteroviruses including coxsackie, adenovirus, influenza, echovirus, parvovirus B19 and herpesvirus. A high index of suspicion,
Abbie Evans   +3 more
doaj   +1 more source

Mesenchymal stromal cells inhibit NLRP3 inflammasome activation in a model of Coxsackievirus B3-induced inflammatory cardiomyopathy [PDF]

open access: yes, 2018
Inflammation in myocarditis induces cardiac injury and triggers disease progression to heart failure. NLRP3 inflammasome activation is a newly identified amplifying step in the pathogenesis of myocarditis.
A Abbate   +43 more
core   +1 more source

A fatal case of fulminant myocarditis after influenza infection with a rapidly progressive course: A case report

open access: yesIDCases
Myocarditis is an inflammation of the heart muscle. The most common cause of myocarditis is viral infections. clinical presentation of acute myocarditis is highly variable and varies from asymptomatic to fulminant heart failure or sudden death. Fulminant
Behnam Shakerian   +1 more
doaj   +1 more source

Modulation of the acute defence reaction by eplerenone prevents cardiac disease progression in viral myocarditis

open access: yesESC Heart Failure, 2020
Left ventricular (LV) dysfunction in viral myocarditis is attributed to myocardial inflammation and fibrosis, inducing acute and long‐time cardiac damage. Interventions are not established.
C. Tschöpe   +12 more
semanticscholar   +1 more source

Long‐term cardiovascular outcomes of immune checkpoint inhibitor‐related myocarditis: A large single‐centre analysis

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1237-1245, April 2025.
Abstract Aims Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI‐related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI‐related adverse events.
Lorenzo Braghieri   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy